Savannah Chrisley‘s prescription weight loss website is under federal microscope… because the FDA warned her not to make false and misleading claims about GLP-1.
The FBI sent Savannah a warning letter last month, obtained by TMZ … informing her they were censoring her website good girl RX and found some problems.
Getty
That said, the federal government took issue with some of the claims her company made about its compounded semaglutide and tezepatide products… The FDA didn’t like her use of phrases like “FDA-approved drugs,” “FDA-approved options” and “clinically proven GLP-1 results.”
The FBI educated Savannah and told her that compounded drug products, such as those offered on her website, were not FDA-approved… They said she implied that her products “had been evaluated for safety and effectiveness when in fact they had not been.”
Getty
Savannah was warned that she was violating federal law… and they gave her 15 business days to correct it or face legal action.
Savannah appears to be taking this warning seriously…her website appears to have made some changes to comply…for example, the wording now reads “clinical study results” instead of “clinically proven”…and there is a disclaimer stating that GLP-1 drugs are not FDA approved.
Savannah told TMZ … “This is about website wording, not patient safety. There are no fines and no disciplinary action. We are proud to help women access licensed doctors and we welcome the FDA’s guidance.”
